Copyright
©The Author(s) 2004.
World J Gastroenterol. Aug 1, 2004; 10(15): 2157-2162
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2157
Published online Aug 1, 2004. doi: 10.3748/wjg.v10.i15.2157
Table 1 HEV ORF2 antigenic peptides
| HEV (origin) | Designation | Amino acid | |
| N’ | C’ | ||
| Expressed in E. coil | |||
| China | ORF2 | 1 | 660 |
| Burma | TrpE-C2 | 221 | 660 |
| Burma | SG3 | 328 | 654 |
| China | ORF2.1 | 394 | 660 |
| Mexico, Burma | 3.2 | 612 | 654 |
| Expressed in insect cells | |||
| Burma | 72 ku | 1 | 660 |
| Pakistan | 63 ku | 112 | 660 |
| Burma | 62 ku | 112 | 636 |
| Pakistan | 55 ku | 112 | 607 |
| Pakistan | 53 ku | 112 | 578 |
| Burma | 50 ku | 112 | 534 |
| DNA vaccine | |||
| Burma | pJHEV | 1 | 660 |
| China | pSVL-ORF3 | 1 | 123 |
- Citation: Wang L, Zhuang H. Hepatitis E: An overview and recent advances in vaccine research. World J Gastroenterol 2004; 10(15): 2157-2162
- URL: https://www.wjgnet.com/1007-9327/full/v10/i15/2157.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i15.2157